Search

everythinglearnresearchcommunity

for

Search:↓

Both HLA-B and MICA are independently linked to alopecia areata.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

ILC1 cells contribute to hair loss in alopecia areata.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Technological advancements and standardization are crucial for improving diagnostic accuracy and laboratory efficiency.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Minoxidil levels measured in human blood.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Bimekizumab effectively treated a man's chronic beard hair loss.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Blocking IL-8 can reduce skin rashes from cancer treatment.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Consider infectious diseases like visceral leishmaniasis before diagnosing autoimmune hepatitis.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.